Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway

Journal of Experimental Medicine

Volumn 208, Issue 9, 2011, Pages 1863-1874

  Potian, Julius A ^a   Rafi, Wasiulla ^a   Bhatt, Kamlesh ^a   McBride, Amanda ^a   Gause, William C ^a,b   Salgame, Padmini ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; CELL SURFACE RECEPTOR; IL4RA PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYTOKINE RELEASE; HELMINTH; HELMINTHIASIS; HISTOPATHOLOGY; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NIPPOSTRONGYLUS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; GENETICS; IMMUNOLOGY; LUNG; MACROPHAGE; MOUSE MUTANT; SIGNAL TRANSDUCTION; STRONGYLE INFECTION; TH1 CELL; TH2 CELL;

ANIMALS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NIPPOSTRONGYLUS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STRONGYLIDA INFECTIONS; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY;

EID: 80052086428     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091473     Document Type: Article

References (58)

1. Actor, J.K., M. Shirai, M.C. Kullberg, R.M. Buller, A. Sher, and J.A. Berzofsky. 1993. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA. 90:948-952.
2. Anthony, R.M., L.I. Rutitzky, J.F. Urban Jr., M.J. Stadecker, and W.C. Gause. 2007. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 7:975-987.
3. Arora, S., Y. Hernandez, J.R. Erb-Downward, R.A. McDonald, G.B. Toews, and G.B. Huffnagle. 2005. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J. Immunol. 174:6346-6356.
4. Babu, S., S.Q. Bhat, N.P. Kumar, S. Jayantasri, S. Rukmani, P. Kumaran, P.G. Gopi, C. Kolappan, V. Kumaraswami, and T.B. Nutman. 2009. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J. Infect. Dis. 200:288-298.
5. Bethony, J., S. Brooker, M. Albonico, S.M. Geiger, A. Loukas, D. Diemert, and P.J. Hotez. 2006. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 367:1521-1532.
6. Bhatt, K., S.P. Hickman, and P. Salgame. 2004. Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis. J. Immunol. 172:2748-2751.
7. Brooker, S., A.C. Clements, and D.A. Bundy. 2006. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv. Parasitol. 62:221-261.
8. Buccheri, S., R. Reljic, N. Caccamo, J. Ivanyi, M. Singh, A. Salerno, and F. Dieli. 2007. IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice. Eur. J. Immunol. 37:729-737.
9. Chan, J., Y. Xing, R.S. Magliozzo, and B.R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
10. Co, D.O., L.H. Hogan, S.I. Kim, and M. Sandor. 2004. Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin. Immunol. 113:130-136.
11. Day, J., A. Friedman, and L.S. Schlesinger. 2009. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc. Natl. Acad. Sci. USA. 106:11246-11251.
12. El Kasmi, K.C., J.E. Qualls, J.T. Pesce, A.M. Smith, R.W. Thompson, M. Henao-Tamayo, R.J. Basaraba, T. König, U. Schleicher, M.S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9:1399-1406.
13. Elias, D., H. Akuffo, A. Pawlowski, M. Haile, T. Schön, and S. Britton. 2005. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine. 23:1326-1334.
14. Elias, D., S. Britton, A. Aseffa, H. Engers, and H. Akuffo. 2008. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine. 26:3897-3902.
15. Fletcher, H.A., P. Owiafe, D. Jeffries, P. Hill, G.A. Rook, A. Zumla, T.M. Doherty, and R.H. Brookes; Vacsel Study Group. 2004. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology. 112:669-673.
16. Freeman, S., F.A. Post, L.G. Bekker, R. Harbacheuski, L.M. Steyn, B. Ryffel, N.D. Connell, B.N. Kreiswirth, and G. Kaplan. 2006. Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J. Interferon Cytokine Res. 26:27-33.
17. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
18. Harris, J., S.A. De Haro, S.S. Master, J. Keane, E.A. Roberts, M. Delgado, and V. Deretic. 2007. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity. 27:505-517.
19. Harvie, M., M. Camberis, S.C. Tang, B. Delahunt, W. Paul, and G. Le Gros. 2010. The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites. Infect. Immun. 78:3753-3762.
20. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66:5167-5174.
21. Herbert, D.R., C. Hölscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 20:623-635.
22. Hogaboam, C.M., C.S. Gallinat, C. Bone-Larson, S.W. Chensue, N.W. Lukacs, R.M. Strieter, and S.L. Kunkel. 1998. Collagen deposition in a nonfibrotic lung granuloma model after nitric oxide inhibition. Am. J. Pathol. 153:1861-1872.
23. Hölscher, C., B. Arendse, A. Schwegmann, E. Myburgh, and F. Brombacher. 2006. Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J. Immunol. 176:1115-1121.
24. Hsieh, C.-S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, and K.M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:547-549.
25. Jankovic, D., M.C. Kullberg, N. Noben-Trauth, P. Caspar, W.E. Paul, and A. Sher. 2000. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J. Immunol. 164:3047-3055.
26. Jung, Y.J., R. LaCourse, L. Ryan, and R.J. North. 2002. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect. Immun. 70:6436-6443.
27. Kahnert, A., P. Seiler, M. Stein, S. Bandermann, K. Hahnke, H. Mollenkopf, and S.H. Kaufmann. 2006. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol. 36:631-647.
28. Lazarevic, V., S. Pawar, and J. Flynn. 2005. Measuring T-cell function in animal models of tuberculosis by ELISPOT. Methods Mol. Biol. 302:179-190.
29. Le Gros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W.E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921-929.
30. Liu, Z., Q. Liu, J. Pesce, J. Whitmire, M.J. Ekkens, A. Foster, J. VanNoy, A.H. Sharpe, J.F. Urban Jr., and W.C. Gause. 2002. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. J. Immunol. 169:6959-6968.
31. Loke, P., I. Gallagher, M.G. Nair, X. Zang, F. Brombacher, M. Mohrs, J.P. Allison, and J.E. Allen. 2007. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179:3926-3936.
32. MacMicking, J.D., R.J. North, R. LaCourse, J.S. Mudgett, S.K. Shah, and C.F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA. 94:5243-5248.
33. Malhotra, I., P. Mungai, A. Wamachi, J. Kioko, J.H. Ouma, J.W. Kazura, and C.L. King. 1999. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J. Immunol. 162:6843-6848.
34. Manca, C., M.B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C.E. Barry III, and G. Kaplan. 2004. Differential monocyte activation underlies strainspecific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72:5511-5514.
35. Marsland, B.J., M. Kurrer, R. Reissmann, N.L. Harris, and M. Kopf. 2008. Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages. Eur. J. Immunol. 38:479-488.
36. Martinez, F.O., L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27:451-483.
37. McKee, A.S., and E.J. Pearce. 2004. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173:1224-1231.
38. Mosser, D.M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73:209-212.
39. Mosser, D.M., and J.P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
40. Müller, U., W. Stenzel, G. Köhler, C. Werner, T. Polte, G. Hansen, N. Schütze, R.K. Straubinger, M. Blessing, A.N. McKenzie, et al. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367-5377.
41. Pearlman, E., J.W. Kazura, F.E. Hazlett Jr., and W.H. Boom. 1993. Modulation of murine cytokine responses to mycobacterial antigens by helminthinduced T helper 2 cell responses. J. Immunol. 151:4857-4864.
42. Qualls, J.E., G. Neale, A.M. Smith, M.S. Koo, A.A. DeFreitas, H. Zhang, G. Kaplan, S.S. Watowich, and P.J. Murray. 2010. Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling. Sci. Signal. 3:ra62.
43. Reece, J.J., M.C. Siracusa, T.L. Southard, C.F. Brayton, J.F. Urban Jr., and A.L. Scott. 2008. Hookworm-induced persistent changes to the immunological environment of the lung. Infect. Immun. 76:3511-3524.
44. Resende Co, T., C.S. Hirsch, Z. Toossi, R. Dietze, and R. Ribeiro-Rodrigues. 2007. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin. Exp. Immunol. 147:45-52.
45. Rodríguez, M., L.I. Terrazas, R. Márquez, and R. Bojalil. 1999. Susceptibility to Trypanosoma cruzi is modified by a previous non-related infection. Parasite Immunol. 21:177-185.
46. Rook, G.A. 2007. Th2 cytokines in susceptibility to tuberculosis. Curr. Mol. Med. 7:327-337.
47. Roy, E., J. Brennan, S. Jolles, and D.B. Lowrie. 2008. Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection. Tuberculosis (Edinb.). 88:197-202.
48. Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai, T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11:936-944.
49. Schlesinger, L.S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
50. Seder, R.A., R. Gazzinelli, A. Sher, and W.E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
51. Sher, A., D. Fiorentino, P. Caspar, E. Pearce, and T. Mosmann. 1991. Production of IL-10 by CD4+ T lymphocytes correlates with downregulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147:2713-2716.
52. Shirey, K.A., L.E. Cole, A.D. Keegan, and S.N. Vogel. 2008. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181:4159-4167.
53. Stewart, G.R., M. Boussinesq, T. Coulson, L. Elson, T. Nutman, and J.E. Bradley. 1999. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin. Exp. Immunol. 117:517-523.
54. Tumitan, A.R., L.G. Monnazzi, F.R. Ghiraldi, E.M. Cilli, and B.M. Machado de Medeiros. 2007. Pattern of macrophage activation in yersiniaresistant and yersinia-susceptible strains of mice. Microbiol. Immunol. 51:1021-1028.
55. van Panhuys, N., S.C. Tang, M. Prout, M. Camberis, D. Scarlett, J. Roberts, J. Hu-Li, W.E. Paul, and G. Le Gros. 2008. In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc. Natl. Acad. Sci. USA. 105:12423-12428.
56. Wangoo, A., T. Sparer, I.N. Brown, V.A. Snewin, R. Janssen, J. Thole, H.T. Cook, R.J. Shaw, and D.B. Young. 2001. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J. Immunol. 166:3432-3439.
57. Weng, M., D. Huntley, I.F. Huang, O. Foye-Jackson, L. Wang, A. Sarkissian, Q. Zhou, W.A. Walker, B.J. Cherayil, and H.N. Shi. 2007. Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J. Immunol. 179:4721-4731.
58. World Health Organization. 2008. Global Tuberculosis Control-Surveillance, Planning, Financing. WHO Press, Geneva, Switzerland. 294 pp.